Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|April 29, 1998

FDA clears Stallion digital package

Stallion Technologies is planning its entry into the medical imaging market after receiving 510(k) clearance for a digital image processing package for dynamic x-ray modalities. Stallion began marketing its X-Sight package to medical imaging OEMs and

Stallion Technologies is planning its entry into the medical imaging market after receiving 510(k) clearance for a digital image processing package for dynamic x-ray modalities. Stallion began marketing its X-Sight package to medical imaging OEMs and major distributors after winning Food and Drug Administration clearance in January.

The main feature of X-Sight is its flexibility, according to Marshall Ma, general manager of the Liverpool, NY, company. The package supports a wide range of x-ray systems, including radiography-fluoroscopy, C-arms, angiography suites, and cardiac catheterization labs. X-Sight also is available in configurations that support high-end techniques such as digital subtraction angiography and biplane cardiac cath. In its basic configuration, X-Sight is capable of resolutions of up to 2048 x 2048 in 10 bits, with 12-bit real-time image processing functions. It also supports acquisition rates of up to 120 fps.

X-Sight supports digital acquisition technologies ranging from analog cameras to CCD-based systems, and the company is working on developing an interface to flat-panel digital sensors in development. Stallion is an engineering services firm that has decided to branch out into medical imaging by developing the software used in X-Sight, Ma said.

Related to this article

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.